Arcus Biosciences, Inc.RCUSNYSE
Loading
Gross Profit Over TimeStrong
Percentile Rank78
3Y CAGR+29.3%
5Y CAGR+25.4%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+29.3%/yr
vs +91.4%/yr prior
5Y CAGR
+25.4%/yr
Recent acceleration
Acceleration
-62.1pp
Decelerating
Percentile
P78
Within normal range
vs 5Y Ago
3.1x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$242.00M-6.2%
2024$258.00M+120.5%
2023$117.00M+4.5%
2022$112.00M-70.8%
2021$383.00M+391.0%
2020$78.00M+420.0%
2019$15.00M+79.6%
2018$8.35M+491.2%
2017$1.41M+207.5%
2016$-1.31M-